1,060 filings
Page 24 of 53
EFFECT
EYPT
EyePoint Pharmaceuticals Inc
2 Nov 18
Notice of effectiveness
12:15am
CORRESP
EYPT
EyePoint Pharmaceuticals Inc
1 Nov 18
Correspondence with SEC
12:00am
S-3/A
EYPT
EyePoint Pharmaceuticals Inc
Shelf registration (amended)
31 Oct 18
5:29pm
8-K
EYPT
EyePoint Pharmaceuticals Inc
31 Oct 18
EyePoint Pharmaceuticals Appoints John Landis, Ph.D., M.S., to Board of Directors
4:01pm
4
EYPT
EyePoint Pharmaceuticals Inc
29 Oct 18
EyePoint Pharmaceuticals / John B. Landis ownership change
4:03pm
3
EYPT
EyePoint Pharmaceuticals Inc
29 Oct 18
EyePoint Pharmaceuticals / John B. Landis ownership change
4:00pm
4
Nancy Lurker
16 Oct 18
EyePoint Pharmaceuticals / Nancy Lurker ownership change
4:00pm
4
EYPT
EyePoint Pharmaceuticals Inc
16 Oct 18
EyePoint Pharmaceuticals / Leonard S Ross ownership change
4:00pm
4
EYPT
EyePoint Pharmaceuticals Inc
16 Oct 18
EyePoint Pharmaceuticals / Dario A. Paggiarino ownership change
4:00pm
8-K
EYPT
EyePoint Pharmaceuticals Inc
15 Oct 18
EyePoint Pharmaceuticals Receives FDA Approval of YUTIQ™ (fluocinolone acetonide intravitreal implant) 0.18 mg
5:13pm
4
Goran Ando
15 Oct 18
EyePoint Pharmaceuticals / GORAN ANDO ownership change
4:05pm
8-K
EYPT
EyePoint Pharmaceuticals Inc
28 Sep 18
EyePoint Pharmaceuticals Reports Fiscal 2018 Fourth Quarter & Full Year Financial Results and Highlights Recent Progress
4:02pm
S-8
EYPT
EyePoint Pharmaceuticals Inc
25 Sep 18
Registration of securities for employees
12:00am
10-K
2018 FY
EYPT
EyePoint Pharmaceuticals Inc
Annual report
18 Sep 18
12:00am
8-K
EYPT
EyePoint Pharmaceuticals Inc
12 Sep 18
Other Events
12:00am
4
EYPT
EyePoint Pharmaceuticals Inc
10 Sep 18
EyePoint Pharmaceuticals / David J Mazzo ownership change
12:00am
S-3/A
EYPT
EyePoint Pharmaceuticals Inc
Shelf registration (amended)
17 Aug 18
9:02am
CORRESP
EYPT
EyePoint Pharmaceuticals Inc
17 Aug 18
Correspondence with SEC
12:00am
4
David Price
3 Aug 18
EyePoint Pharmaceuticals / David Price ownership change
4:06pm